证券代码：603086 证券简称：先达股份 公告编号：2023-018 山东先达农化股份有限公司 关于召开2022年度业绩暨现金分红说明会的公告 （三）召开方式：上证路演中心网络互动 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、说明会类型 山东先达农化股份有限公司（以下简称"公司"）已于 2023 年 04 月 26 日在 上海证券交易所网站（www.sse.com.cn）及指定信息披露媒体披露了公司 2022 年年度报告。为便于广大投资者更全面深入地了解公司 2022 年度经营成果及财 务状况，公司计划于 2023 年 05 月 15 日下午 14:00-15:00 通过网络互动形式召 开 2022 年度业绩暨现金分红说明会，就投资者普遍关注的问题进行沟通与交流， 广泛听取投资者的意见和建议。 二、说明会召开的时间、地点 （一）召开时间：2023 年 05 月 15 日下午 14:00-15:00 （二）召开地点：上证路演中心（http://roadshow.sseinfo.com/） 1 会议 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 547,800,695.47, representing a decrease of 2.39% compared to the same period last year[5] - The net profit attributable to shareholders was CNY 44,424,279.36, down 41.36% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 35,864,989.27, a decline of 48.56% compared to the previous year[5] - Basic earnings per share were CNY 0.14, reflecting a decrease of 41.67% compared to the same period last year[6] - Net profit for Q1 2023 was CNY 45.22 million, down 40.3% from CNY 75.76 million in Q1 2022[17] - The company reported a gross profit margin of approximately 13.1% in Q1 2023, down from 18.9% in Q1 2022[26] Cash Flow - The net cash flow from operating activities was negative at CNY -40,800,207.31, a decrease of 135.87% year-on-year[5] - Cash flow from operating activities showed a net outflow of CNY 40.80 million, a significant decline from a net inflow of CNY 113.75 million in Q1 2022[21] - Cash inflow from investment activities was CNY 707.01 million, while cash outflow was CNY 893.10 million, resulting in a net cash outflow of CNY 186.08 million[21] - Cash flow from investing activities showed a net outflow of $20,935,755.40 in Q1 2023, slightly worse than the outflow of $19,961,459.72 in Q1 2022[29] - Cash flow from financing activities resulted in a net inflow of $30,000,000.00 in Q1 2023, down from $60,000,000.00 in Q1 2022, reflecting a 50% decrease[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,638,673,720.36, an increase of 8.53% from the end of the previous year[6] - The total liabilities of the company increased to CNY 1,408,925,815.71 from CNY 1,171,764,894.48, marking an increase of approximately 20.2%[15] - The company's equity attributable to shareholders rose to CNY 2,224,241,184.17 from CNY 2,176,337,674.88, reflecting an increase of about 2.2%[15] - Total assets as of March 31, 2023, were CNY 2,367,481,858.22, an increase from CNY 2,167,632,518.03 at the end of 2022[25] - Total liabilities increased to CNY 844,979,124.62 in Q1 2023 from CNY 653,030,638.21 in Q4 2022[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,042[9] - The company's current assets totaled CNY 2,271,940,933.50, up from CNY 2,025,041,978.72, indicating an increase of about 12.2%[14] Inventory and Expenses - The company's inventory increased to CNY 935,695,266.43 from CNY 639,667,256.31, representing a growth of approximately 46.2%[13] - Research and development expenses for Q1 2023 were CNY 8,507,368.09, a decrease from CNY 10,219,808.23 in Q1 2022[26] - The company reported an increase in financial expenses to CNY 7.65 million, up from CNY 1.73 million in Q1 2022[16] Non-Recurring Gains and Losses - The company reported non-recurring gains of CNY 8,559,290.09, primarily from government subsidies and other income[7] - The decline in net profit was mainly attributed to a decrease in the sales prices of the company's main products[7] - Other income for Q1 2023 was CNY 9.18 million, significantly higher than CNY 1.59 million in Q1 2022[16] - The company incurred an investment loss of CNY 2.15 million in Q1 2023, contrasting with an investment gain of CNY 3.59 million in the same period last year[17]

Financial Performance - The company's operating revenue for 2022 reached CNY 3,125,923,462.62, representing a 41.92% increase compared to CNY 2,202,538,106.69 in 2021[19] - The net profit attributable to shareholders of the listed company was CNY 381,199,039.53, a significant increase of 114.90% from CNY 177,380,335.82 in the previous year[19] - The net profit after deducting non-recurring gains and losses was CNY 420,217,141.57, up 178.94% from CNY 150,648,746.13 in 2021[19] - The net cash flow from operating activities was CNY 364,450,131.02, an increase of 62.62% compared to CNY 224,108,606.00 in 2021[19] - As of the end of 2022, the net assets attributable to shareholders of the listed company were CNY 2,176,337,674.88, an 18.42% increase from CNY 1,837,878,062.69 at the end of 2021[19] - Total assets at the end of 2022 amounted to CNY 3,352,809,660.06, reflecting a 23.03% increase from CNY 2,725,106,027.36 in 2021[19] - Basic earnings per share rose to 1.23 yuan, up 115.79% from 0.57 yuan in 2021[20] - The weighted average return on equity increased to 18.63%, up 8.58 percentage points from 10.05% in 2021[20] - The cash dividend payout ratio for the year was 20.37%[4] - The company declared a cash dividend of CNY 55,471,500, which accounts for 31.27% of the net profit attributable to ordinary shareholders in the consolidated financial statements[156] Dividend Policy - The company plans to distribute a cash dividend of CNY 2.50 per 10 shares (including tax) and to increase capital by 4 shares for every 10 shares held[4] - The company has a clear and defined dividend policy that complies with the company's articles of association and shareholder resolutions[154] - The company emphasizes a stable cash dividend policy, aiming to distribute at least 10% of the net profit attributable to shareholders in cash annually[153] - The company plans to conduct cash dividends after the annual general meeting, with a goal of maintaining a cumulative distribution of at least 30% of the average distributable profit over three consecutive years[153] Research and Development - The company focuses on the research and development of high-end herbicides and has established a strong R&D team[38] - The company is committed to innovation and has established an innovation research institute to develop new compounds and technologies[38] - Research and development expenses rose to CNY 144,288,423.00, marking a 47.14% increase year-on-year[44] - The total R&D investment reached ¥161,433,327.51, accounting for 5.16% of total revenue[54] - The company is committed to increasing R&D investment to accelerate the development of differentiated herbicides tailored to the Chinese market[113] Market Expansion and Strategy - The company is actively pursuing market expansion and technological innovation to ensure sustainable growth[27] - The company is currently constructing a project with a production capacity of 1,000 tons of imidazolinone and 3,000 tons of pesticide intermediates, which will significantly enhance production capabilities[28] - The company is focusing on high-quality development and innovation-driven strategies to inject new momentum into future growth[29] - The company plans to enhance its domestic market development and reduce reliance on foreign markets, focusing on innovative products and technology-driven growth[111] Environmental Management - The company has implemented various pollution control facilities, including RTO regenerative thermal oxidizers and advanced wastewater treatment systems, which are operating normally[176] - The company has maintained effective pollution control measures, with wastewater discharge meeting standards and no environmental pollution incidents reported during the reporting period[166] - The total COD discharge was 4.03 tons, with a concentration of 91.2 mg/L, which did not exceed the permitted limits[167] - The company has received environmental impact assessment approvals for several projects, including a 1500 tons pesticide raw material project and a 3500 tons pesticide intermediate project[179] Corporate Governance - The company strictly adheres to the Company Law and Securities Law, ensuring compliance in governance and operations[129] - The board of directors and supervisory board operate in compliance with legal and regulatory requirements, ensuring effective governance[130] - The company has implemented strict information disclosure practices, ensuring that all shareholders receive fair and timely information[130] - The independent directors have fulfilled their responsibilities and played their due role in the decision-making process[154] Risk Management - The company has not identified any significant risks that could materially affect its operations during the reporting period[6] - The company is facing market competition risks due to increased supply and a downward trend in industry prices, which may impact performance[121] - The company will implement foreign exchange risk management strategies, including forward contracts, to minimize the impact of currency fluctuations on profitability[124] Employee Management - The total number of employees in the parent company and major subsidiaries is 1,899, with 386 in the parent company and 1,513 in subsidiaries[148] - The company has a structured compensation policy that links remuneration to performance, with a focus on market-oriented salary levels[149] - The company has established a training plan that combines online and offline methods to enhance employee skills and align with company development needs[151] Compliance and Auditing - The company has engaged Da Hua Accounting Firm for auditing services, with a remuneration of 550,000 RMB, and has maintained this auditor for 9 years[195] - There are no non-operating fund occupations by controlling shareholders or related parties during the reporting period[192] - The company has not reported any significant accounting errors that would require correction during the reporting period[193]

Group 1: Event Details - The company will participate in the "2022 Annual Investor Online Reception Day" on November 16, 2022 [2] - The event is organized by the Shandong Securities Regulatory Bureau and the Shandong Listed Companies Association [2] - The online platform for the event is provided by Shenzhen Panorama Network Co., Ltd. [2] Group 2: Participation Information - The event will take place from 14:00 to 16:00 on November 16, 2022 [2] - Company executives, including General Manager Mr. Men Liang and Secretary of the Board and CFO Mr. Jiang Guangtong, will engage with investors during the event [2] - Investors are encouraged to actively participate in the online interaction [2] Group 3: Company Assurance - The board of directors guarantees the announcement's content is free from false records, misleading statements, or significant omissions [2] - The board takes individual and joint responsibility for the truthfulness, accuracy, and completeness of the content [2]

Financial Performance - The company's operating revenue for Q3 2022 reached ¥806,325,053.31, representing a year-on-year increase of 70.55%[4] - The net profit attributable to shareholders for Q3 2022 was ¥126,936,250.46, a significant increase of 417.94% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥166,851,209.04, reflecting a year-on-year increase of 682.61%[4] - The basic earnings per share for Q3 2022 was ¥0.41, up 412.50% from the previous year[4] - In Q3 2022, the company's net profit reached CNY 324,750,870.95, a significant increase from CNY 83,769,439.41 in Q3 2021, representing a growth of approximately 287%[18] - The operating profit for Q3 2022 was CNY 354,997,648.41, compared to CNY 103,342,701.13 in the same period last year, indicating a year-over-year increase of about 243%[18] - Basic and diluted earnings per share for Q3 2022 were CNY 1.05, compared to CNY 0.27 in Q3 2021, representing an increase of approximately 288%[19] - The total comprehensive income for Q3 2022 was CNY 324,750,870.95, compared to CNY 83,769,439.41 in Q3 2021, indicating a substantial increase of approximately 287%[19] Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached CNY 2,470,082,481.24, a significant increase from CNY 1,510,387,837.24 in the same period of 2021, representing a growth of approximately 63.6%[17] - Total operating costs for the first three quarters of 2022 were CNY 2,042,916,592.88, compared to CNY 1,415,898,719.61 in the previous year, indicating an increase of about 44.2%[17] - Total revenue from sales of goods and services for the first nine months of 2022 was CNY 2,184,624,331.87, compared to CNY 1,346,003,199.90 in the previous year, marking an increase of about 62%[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,585,644,377.72, an increase of 31.58% compared to the end of the previous year[4] - As of September 30, 2022, total current assets were CNY 2,372,738,937.65, compared to CNY 1,668,730,530.62 at the end of 2021, marking an increase of about 42.3%[13] - Total liabilities as of September 30, 2022, were CNY 1,467,765,933.31, up from CNY 887,227,964.67 at the end of 2021, representing an increase of approximately 65.4%[14] - The total assets of the company reached CNY 3,585,644,377.72 as of September 30, 2022, compared to CNY 2,725,106,027.36 at the end of 2021, indicating a growth of approximately 31.6%[15] - The company's equity attributable to shareholders was CNY 2,117,878,444.41 as of September 30, 2022, compared to CNY 1,837,878,062.69 at the end of 2021, reflecting an increase of about 15.3%[15] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥463,735,849.03, showing a year-on-year increase of 470.40%[4] - Cash flow from operating activities for the first nine months of 2022 was CNY 463,735,849.03, up from CNY 81,299,975.73 in the same period of 2021, reflecting a growth of approximately 471%[22] - The company reported a net cash outflow from investing activities of CNY -582,409,775.93 in the first nine months of 2022, compared to CNY -311,521,138.17 in the same period of 2021[23] - The cash and cash equivalents at the end of Q3 2022 stood at CNY 229,654,525.04, a decrease from CNY 54,123,376.46 at the end of Q3 2021[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,561[10] - The largest shareholder, Wang Xianquan, held 33.16% of the shares, totaling 103,002,099 shares[10] Research and Development - Research and development expenses for the first three quarters of 2022 amounted to CNY 108,269,538.33, up from CNY 74,798,721.60 in 2021, reflecting a growth of approximately 44.7%[17] - Research and development expenses for Q3 2022 were ¥40,166,908.95, compared to ¥34,805,579.34 in Q3 2021, reflecting increased investment in innovation[29] Inventory and Accounts Receivable - The company experienced a significant increase in accounts receivable, which rose to CNY 385,251,684.70 as of September 30, 2022, from CNY 267,623,227.59 at the end of 2021, reflecting a growth of about 44%[25] - The company's inventory decreased from ¥208,276,941.28 to ¥191,642,386.56, indicating improved inventory management[26]

Financial Performance - The company's operating revenue for the first half of 2022 reached ¥1,663,757,427.93, representing a 60.35% increase compared to ¥1,037,610,224.84 in the same period last year[18]. - Net profit attributable to shareholders was ¥197,814,620.49, a significant increase of 233.80% from ¥59,261,649.65 in the previous year[18]. - The net cash flow from operating activities was ¥246,870,494.55, a remarkable turnaround from a negative cash flow of ¥55,362,649.08 in the same period last year, marking a 545.92% improvement[18]. - Basic earnings per share increased to ¥0.64, up 236.84% from ¥0.19 in the same period last year[19]. - The weighted average return on net assets improved to 10.21%, an increase of 6.74 percentage points from 3.47% in the previous year[19]. - The company reported a significant increase in trading financial assets, which reached CNY 324,460,189.59, up 3,601.65% from CNY 8,765,289.60[48]. - The company reported a notable increase in development expenditures to ¥26,607,894.47, up from ¥13,962,518.98, which is an increase of approximately 90.9%[108]. - The company recorded a significant increase in operating profit, which reached ¥216,751,993.82, compared to ¥73,224,800.13 in the first half of 2021[116]. Assets and Liabilities - The total assets of the company increased by 24.67% to ¥3,397,391,683.24 from ¥2,725,106,027.36 at the end of the previous year[18]. - Total liabilities rose to ¥1,410,198,479.27, compared to ¥887,227,964.67, indicating an increase of about 58.9%[109]. - Owner's equity reached ¥1,987,193,203.97, up from ¥1,837,878,062.69, reflecting a growth of approximately 8.1%[109]. - The total current assets increased to CNY 2,270,561,727.34 from CNY 1,668,730,530.62, reflecting a growth of approximately 36%[107]. - The total non-current assets amounted to ¥1,126,829,955.90, compared to ¥1,056,375,496.74, showing a growth of about 6.6%[108]. Research and Development - The company maintains a focus on research and development, collaborating with universities to enhance its innovation capabilities and product development[30]. - Research and development expenses rose to CNY 66,752,561.05, marking a 36.70% increase from CNY 48,831,986.77, reflecting the company's commitment to innovation[44][45]. - The company has established a strong R&D team and increased investment in R&D, leading to the successful market launch of new products such as quikazone[33]. - The company is investing heavily in R&D, with a budget allocation of 200 million RMB for new technology development[85]. Market Position and Strategy - The company is positioned as a leader in the selective herbicide segment, leveraging advantages in technology innovation, quality, scale, and brand[32]. - The company achieved overseas sales of $145 million in the first half of 2022, surpassing the total export amount for the entire year of 2021[40]. - The company has established a comprehensive sales model, including direct sales to domestic agricultural enterprises and both self-operated and indirect exports for international markets[31]. - The company plans to continue focusing on market expansion and new product development to sustain growth in the upcoming quarters[118]. Environmental Responsibility - The company’s pollution prevention facilities operated normally, with wastewater and air emissions meeting standards[61]. - The company has not reported any environmental pollution incidents during the reporting period[61]. - The company has established various environmental protection facilities, including RTO regenerative thermal oxidizers and multiple wastewater treatment technologies, which are operating normally during the reporting period[71]. - The company is committed to reducing carbon emissions and has taken measures to fulfill its environmental responsibilities, although specific details were not disclosed in the report[78]. Shareholder Information - The company distributed cash dividends of 5,547.15 million (including tax) to shareholders, with a payout of 2.50 RMB per 10 shares[93]. - The number of ordinary shareholders reached 15,013 by the end of the reporting period[97]. - The largest shareholder, Wang Xianquan, holds 103,002,099 shares, representing 33.16% of the total shares[99]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties[90]. Financial Reporting and Governance - The company approved the 2021 annual financial report and budget for 2022 during the shareholder meeting[55]. - The company's financial statements were approved by the board of directors on August 18, 2022[144]. - The financial statements are prepared based on the assumption of going concern, in accordance with the relevant accounting standards[149]. - The company has evaluated its ability to continue as a going concern for the next 12 months and found no significant doubts regarding its ability to continue operations[147].

Financial Performance - The company's operating revenue for 2021 was CNY 2,202,538,106.69, representing a 16.19% increase compared to CNY 1,895,595,666.25 in 2020[19]. - The net profit attributable to shareholders of the listed company was CNY 177,380,335.82, a slight increase of 0.76% from CNY 176,034,335.10 in the previous year[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 8.66% to CNY 150,648,746.13 from CNY 164,940,201.50 in 2020[19]. - The net cash flow from operating activities was CNY 224,108,606.00, down 37.99% from CNY 361,385,546.72 in 2020[19]. - The total assets at the end of 2021 were CNY 2,725,106,027.36, an increase of 16.71% from CNY 2,335,002,206.40 at the end of 2020[19]. - The net assets attributable to shareholders of the listed company increased by 7.87% to CNY 1,837,878,062.69 from CNY 1,703,781,974.56 in 2020[19]. - The company's asset-liability ratio stood at 32.56%[25]. - Operating costs increased to CNY 1,701,380,763.24, reflecting a year-on-year rise of 24.34% due to higher sales volume and raw material prices[37]. - The gross profit margin for the main business decreased by 5.08 percentage points to 22.70%[40]. - Domestic sales revenue was CNY 807,129,049.04, with a decrease in gross margin by 12.51 percentage points to 16.77%[40]. Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 2.50 per 10 shares, totaling CNY 55,471,500, with a cash dividend payout ratio of 31.27%[3]. - The company distributed cash dividends of 3.50 RMB per 10 shares, totaling 55.47 million RMB[20]. - The company implements a stable profit distribution policy, prioritizing cash dividends, with a minimum annual cash distribution of 10% of the net profit attributable to shareholders[135]. - The cumulative distributable profit of the company is positive, and the company has no major investment plans or significant cash expenditures exceeding 30% of the latest audited net assets within the next twelve months[135]. - The company aims to distribute at least 30% of the average distributable profit over three consecutive years in cash dividends, provided there are no unremedied losses from previous years[136]. - The company has a cash dividend policy that allows for mid-term distributions based on the company's profitability and funding needs[135]. Research and Development - Research and development expenses amounted to CNY 98,060,123.52, up by 2.18% from the previous year[37]. - The company employed 187 R&D personnel, representing 10.75% of the total workforce[48]. - The company has established partnerships with universities for collaborative research on new compound development, enhancing its technological innovation capabilities[67]. - The company is focusing on high-end formulation registration and overseas market development, achieving significant benefits in 2021[28]. - The company is advancing the registration of innovative compounds domestically and expanding its overseas market registration efforts, targeting Southeast Asia, Central America, and Latin America[102]. Production and Capacity - The company expanded production capacity with the successful trial production of two major raw material workshops, increasing annual production capacity by 5,000 tons[25]. - The company's production capacity for acetochlor is 3,000 tons annually, with an additional 5,000 tons in trial production, further consolidating its market position[34]. - The company's herbicide production capacity is designed at 13,500 tons with a utilization rate of 69.31%[73]. - The fungicide production capacity is designed at 2,500 tons with a utilization rate of 100.32% and an additional 5,000 tons under construction expected to be completed by June 2022[73]. Environmental Compliance - The company maintained compliance with environmental regulations, with wastewater and air emissions meeting the required standards[149][150]. - The total annual COD discharge was 3.827 tons, with a concentration of 97.10 mg/L, well within the permitted limits[149]. - The company has implemented various environmental protection facilities, including RTO thermal oxidation systems and wastewater treatment technologies, which are operating normally[157]. - The company emphasizes strict safety management and has enhanced training and emergency response capabilities to improve risk control in production safety[165]. Corporate Governance - The company maintained strict compliance with the Company Law and relevant regulations, ensuring no guarantees were provided to controlling shareholders or their affiliates[107]. - The company has implemented measures to maintain independence from its controlling shareholders in terms of assets, personnel, finance, and operations[107]. - The company’s independent directors have not reported any conflicts of interest or significant changes in competitive conditions affecting the company[108]. - The company has successfully completed the election of its fourth board of directors and supervisory board during the annual general meeting[108]. Market Position and Strategy - The company is a leading player in the selective herbicide segment, focusing on technological innovation in herbicide varieties and application techniques, with major products ranking among the top in domestic production capacity[61]. - The company is actively pursuing the development of environmentally friendly pesticides in response to increasing demand for green products and stricter regulations[30]. - The company aims to enhance its domestic market product innovation and reduce reliance on foreign markets, aiming to develop high-value products and increase domestic marketing efforts[89]. Risk Management - The company faces market competition risks due to increased product input from international pesticide giants and domestic competitors, which may lead to price declines and reduced profit margins[103]. - The company is exposed to raw material price volatility risks, primarily influenced by international oil prices and market supply-demand dynamics, which could impact operational performance[103]. - The company has implemented a performance evaluation system reform to enhance management quality and incentivize productivity through clear metrics and accountability[99].

Revenue and Profitability - Revenue for Q1 2022 reached ¥561,203,087.34, an increase of 25.80% compared to the same period last year[5] - Net profit attributable to shareholders was ¥75,757,675.73, representing a significant increase of 266.00% year-on-year[5] - Basic earnings per share (EPS) stood at ¥0.34, up 161.54% from the same quarter last year[5] - Total operating revenue for Q1 2022 was CNY 561,203,087.34, an increase of 25.8% compared to CNY 446,091,252.68 in Q1 2021[14] - Net profit for Q1 2022 reached CNY 75,757,675.73, compared to CNY 20,699,023.43 in Q1 2021, representing a significant increase of 265.5%[15] - Earnings per share for Q1 2022 were CNY 0.34, up from CNY 0.13 in Q1 2021, indicating a growth of 161.5%[15] - The company reported a total profit of CNY 86,965,183.79 for Q1 2022, compared to CNY 24,426,239.64 in Q1 2021, representing an increase of 256.1%[15] - The total operating profit for Q1 2022 was CNY 33,230,173.58, up from CNY 7,190,812.33 in the same period last year, indicating a growth of 361.5%[25] Cash Flow and Liquidity - Net cash flow from operating activities was ¥113,749,921.62, a remarkable increase of 481.43% compared to the previous year[5] - The net cash flow from operating activities for Q1 2022 was ¥113,749,921.62, a significant improvement compared to a negative cash flow of ¥29,821,973.74 in Q1 2021, indicating a recovery in operational performance[18] - Cash received from sales of goods and services in Q1 2022 was CNY 591,658,321.58, compared to CNY 422,634,877.90 in Q1 2021, marking an increase of 40.0%[17] - The cash flow from operating activities showed a net outflow of CNY 17,235,351.07 in Q1 2022, worsening from a net outflow of CNY 9,212,901.32 in Q1 2021[28] - Cash and cash equivalents at the end of Q1 2022 amounted to CNY 91,860,903.25, an increase from CNY 53,860,548.77 at the end of Q1 2021[28] Assets and Liabilities - Total assets increased by 13.82% to ¥3,101,582,176.71 compared to the end of the previous year[5] - Total current assets as of March 31, 2022, amounted to CNY 2,026,075,092.48, an increase from CNY 1,668,730,530.62 at the end of 2021[11] - Total liabilities as of Q1 2022 amounted to CNY 1,184,633,191.61, compared to CNY 887,227,964.67 in the previous year, reflecting a growth of 33.5%[14] - The total liabilities amounted to ¥618,148,538.00, up from ¥416,530,570.00 in the previous year, reflecting increased financial obligations[23] - The company reported a total asset value of ¥2,046,473,077.68 as of March 31, 2022, an increase from ¥1,814,865,669.72 at the end of 2021[22] Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,110[8] - The top 10 shareholders hold a combined 80.92% of the shares, with the largest shareholder, Wang Xianquan, owning 33.16%[8] - Total equity attributable to shareholders reached CNY 1,916,948,985.10 in Q1 2022, up from CNY 1,837,878,062.69 in Q1 2021, an increase of 4.3%[14] - The company’s equity totaled ¥1,428,324,539.68 as of March 31, 2022, compared to ¥1,398,335,099.72 at the end of 2021, showing a slight increase in shareholder equity[23] Research and Development - Research and development expenditures increased by 30.09% to ¥18,163,243.01, reflecting higher investment in compound development[7] - Research and development expenses for Q1 2022 were CNY 25,535,345.90, compared to CNY 22,991,964.88 in Q1 2021, showing an increase of 11.0%[14] - Research and development expenses for Q1 2022 were CNY 10,219,808.23, slightly down from CNY 11,110,406.19 in Q1 2021[24] Inventory and Borrowings - The company reported a 34.13% increase in inventory, totaling ¥684,072,180.17, due to preparations for domestic market product sales[7] - Short-term borrowings rose by 200.00% to ¥90,000,000.00, aimed at increasing cash flow reserves for operations[7] - Short-term borrowings rose to CNY 90,000,000.00 from CNY 30,000,000.00, indicating a significant increase in leverage[11] - Inventory increased to CNY 684,072,180.17 from CNY 510,019,926.59 at the end of 2021, reflecting a growth of approximately 34.1%[10] Other Financial Metrics - The weighted average return on equity (ROE) improved by 2.83 percentage points to 4.04%[5] - Non-recurring gains and losses totaled ¥6,040,845.40 after tax adjustments[6] - The deferred income tax liabilities decreased to CNY 531,239.89 in Q1 2022 from CNY 1,220,237.19 in Q1 2021, a reduction of 56.4%[14] - The company reported a financial income of CNY 806,444.10 in Q1 2022, a recovery from a loss of CNY 1,731,699.66 in Q1 2021[25] - The total comprehensive income for Q1 2022 was CNY 28,438,459.17, which is the same as the net profit, indicating no other comprehensive income items[25]

Group 1: Event Details - The company will participate in the "2021 Annual Investor Online Reception Day" on November 16, 2021 [2] - The event will be held online from 14:00 to 16:00 [2] - Investors can join the event via the "Panjing Roadshow" website [2] Group 2: Company Representatives - The company's Secretary of the Board, Jiang Guangtong, will participate in the event [2] - The Chief Financial Officer, Jiang Guangtong, will also be present [2] - The Securities Affairs Representative, Han Enjuan, will engage with investors during the event [2] Group 3: Purpose and Commitment - The event aims to enhance interaction and communication with investors [2] - The company emphasizes the accuracy and completeness of the announcement, ensuring no misleading information is presented [2]

公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 2021 年第三季度报告 证券代码：603086 证券简称：先达股份 山东先达农化股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 | | 年初至报告期末 比上年同期增减 | | --- | --- | --- | --- | --- | | | | 年同期增减变 | 年初至报告期末 | | | | | 动幅度(%) | | 变动幅度(%) | | 营业收入 | 472,777,612.40 | 29.28 | 1,510,387,837.24 | 13.4 ...